Tired of the FTSE 100’s low returns? Consider these large-caps that’ve doubled in just two years

The FTSE 100 (INDEXFTSE: UKX) may be famous for its income focus, but these constituents show it also harbours growth stars.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

With the FTSE 100 returning a miserable 12.5% over the past five years, growth investors would be forgiven for ignoring the large-cap index entirely in favour of riskier mid- or small-cap stocks. However, within this mediocre-at-best performance, a few large-cap stocks have more than doubled in just the last few years.

A sea change in opinion

One is online grocer Ocado (LSE: OCDO), whose share price has risen 130% in the past five years… and over 200% in just the past 12 months. The key to this rapid share price run-up is the long-term potential from the proprietary systems the group has developed to run highly-automated grocery delivery logistics facilities.

Understandably, investors are more enamoured with this part of the business that involves patent-protected technology, the potential for high profitability, and ability to sell anywhere in the world than the cost-sensitive, low-margin online grocery delivery business that it’s still best known for in the UK.

That said, the future for Ocado from here is unlikely to be all sunshine and butterflies. The company’s market cap has rocketed to £6.1bn, while analysts are expecting losses for each of the next two years as management builds out the delivery warehouses for international partners. As operations are still loss-making, this means investors could be tapped for funds once again, as they have been twice over the past year.

Also, with its valuation built almost entirely on its long-term potential, there could be significant share price volatility over the next few years if any international contracts are cancelled, delayed, or end up being too expensive.

Ocado is in a better position than it has been in years as long-promised international agreements are being signed, one after the other. But with a sky-high valuation, recent share sales by insiders, and little information on the particulars of its distribution agreements, I’m happy to sit on the sideline for the time being.

A Middle East money spinner 

An even more impressive performer than Ocado has been Middle East healthcare firm NMC Health (LSE: NMC), whose share price has risen nearly ten-fold in just the past five years. That’s thanks to soaring demand for its healthcare facilities across the Emirates and Saudi Arabia, plus a series of acquisitions that have added to its clinic numbers and expanded its offerings into everything from IVF treatment to home nursing.

In the half year to June, the group’s revenue rose 20.2% to $932m, while higher occupancy rates at its hospitals and acquisition synergies boosted EBITDA by 32.1% to $225.5m. A recently-announced joint venture to bulk up the group’s offerings in Saudi Arabia should also provide significant growth potential over the medium term as healthcare spending in the Kingdom is relatively low compared to Western nations. But it’s rising fast as incomes increase and rates of chronic disease rise.

Looking forward, the group still has considerable potential to grow by increasing occupancy rates at its facilities, branching out into extra services, and expanding into neighbouring countries. While net debt of $1,152m at period-end is worryingly high, and its valuation of 32 times forward earnings is lofty, investors looking for a cash-generative business with long-term tailwinds at its back, plus plenty of expansion opportunities, may find NMC Health an interesting growth option to back for the long-term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Looking for cheap growth shares? Here’s one I think investors MUST consider right now

Market jitters over the global economy mean many top growth shares continue to trade cheaply. Here's one of my favourite…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Dividend Shares

Buying 500 Vodafone shares could generate a passive income of…

Jon Smith explains why Vodafone stock still offers him an above-average dividend yield despite the recent dividend cut.

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing For Beginners

3 ways I’m trying to protect my FTSE stock portfolio from rising geopolitical tensions

Jon Smith talks through different measures, including buying gold-related FTSE stocks, that can help his portfolio ride out volatility.

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

As oil prices tick upwards, should investors buy BP shares?

Dr James Fox takes a closer look at BP shares as oil prices push higher on the back of heightened…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

I love this grocer… so, should I buy Ocado shares?

Ocado shares are not looking healthy. The stock has truly been through the mill in recent years but is there…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

£10,000 invested in Raspberry Pi shares 1 year ago are now worth…

The Raspberry Pi share price has been rather volatile over the past 12 months with investors trying to figure out…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

With an 8% dividend yield, are Legal & General shares a screaming buy?

Life insurance companies are often some of the FTSE 100’s most eye-catching dividend shares. But what do investors need to…

Read more »

UK supporters with flag
Investing Articles

These 2 FTSE 100 stocks are up by more 100% so far this year!

Our writer is wondering if he should chase these surging FTSE 100 stocks, or whether investors like himself have already…

Read more »